Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

166
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
166
Hypertension I: Introduction01:28

Hypertension I: Introduction

262
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
262
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

112
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
112
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

671
Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
671
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

207
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
207
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

3.4K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypertension and cardiometabolic multimorbidity: an analysis of 3.4 million participants from the global May Measurement Month blood pressure screening campaign.

BMJ public health·2026
Same author

The content and processes of patient-derived quality of care indicators for people living with multiple long-term conditions (MLTC): A scoping review.

Journal of multimorbidity and comorbidity·2026
Same author

The role of community-based blood pressure screening in improving hypertension care.

Lancet (London, England)·2026
Same author

Effect of intensive blood pressure and blood glucose control on cardiovascular outcomes driven by reductions in cardiovascular death and nephropathy: win ratio analysis of ADVANCE trial.

European heart journal. Cardiovascular pharmacotherapy·2026
Same author

Blood Pressure Parameters and Risk of Cognitive Decline and Dementia in Type 2 Diabetes: Results From the ADVANCE Trial.

Journal of the American Heart Association·2026
Same author

Trends in primary care and hospital admission episodes for infectious intestinal disease in North-West London, 2015-2024.

BJGP open·2026

Related Experiment Video

Updated: Nov 6, 2025

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness
05:51

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness

Published on: May 3, 2018

17.9K

Variation in hypertension clinical practice guidelines: a global comparison.

Richu Philip1, Thomas Beaney1, Nick Appelbaum2

  • 1Department of Primary Care and Public Health, Imperial College London, London, UK.

BMC Medicine
|May 12, 2021
PubMed
Summary

Clinical practice guidelines (CPGs) for hypertension show consistency in diagnosis and target blood pressure (BP) but significant variation in treatment recommendations, especially between high- and low-income countries.

More Related Videos

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.8K
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.7K

Related Experiment Videos

Last Updated: Nov 6, 2025

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness
05:51

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness

Published on: May 3, 2018

17.9K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.8K
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.7K

Area of Science:

  • Cardiology
  • Public Health
  • Health Policy

Background:

  • Hypertension is a leading global health burden, impacting 1.39 billion individuals worldwide.
  • Clinical practice guidelines (CPGs) aim to standardize hypertension management, but inconsistencies exist.
  • Understanding variations in CPGs across different income settings is crucial for addressing global health disparities.

Purpose of the Study:

  • To analyze global variations in hypertension CPGs.
  • To assess differences in diagnostic thresholds, staging, treatment recommendations, and target blood pressure (BP).

Main Methods:

  • Conducted a systematic search of MEDLINE and country-specific grey literature for hypertension CPGs (2010-2020).
  • Extracted data on diagnosis, staging, treatment, and target BP from selected CPGs.
  • Analyzed variations across CPGs, stratified by World Bank income settings.

Main Results:

  • Analyzed 48 CPGs from diverse income settings.
  • Most CPGs defined hypertension as BP ≥140/90 mmHg and recommended a target BP <140/90 mmHg.
  • Significant variation found in pharmacological treatment, with low-income countries favoring diuretics and higher-income countries offering more drug choices and earlier dual-drug therapy initiation.

Conclusions:

  • Hypertension CPGs demonstrate consistency in definition and target BP but significant variability in treatment strategies.
  • Treatment variations, particularly in drug choice and initiation timing, are linked to country income levels.
  • Further research into the drivers of these treatment variations is essential to improve global hypertension management outcomes.